Researchers in developing countries are trying to find treatments for conditions that affect the poorest people. But the system is stacked against their therapies.
Tag: Clinical Trials
Could Longevity Drugs for Dogs Extend Your Pet’s Life?
Longevity drugs for our canine companions are moving closer to reality. They also raise questions about what it might mean to succeed.
Gonorrhea Is Becoming Drug Resistant. Scientists Just Found a Solution.
A new antibiotic, zoliflodacin, is as effective as the current standard of care. Its creation may hasten the arrival of other needed antibiotics.
Ending TB Is Within Reach — So Why Are Millions Still Dying?
Tuberculosis has passed Covid as the top infectious disease killer, despite new medicines and better diagnostic tools.
New Marburg Outbreaks in Africa Raise Alarm About the Deadly Virus’s Spread
The spread of the Ebola-like virus has claimed lives but could be a crucial chance to test a vaccine — if supplies and researchers are mobilized in time.
Why the Odds Are Stacked Against a Promising New Covid Drug
A new drug quashes all coronavirus variants. But regulatory hurdles and a lack of funding make it unlikely to reach the U.S. market anytime soon.
The Only H.I.V. Vaccine in Advanced Trials Has Failed. What Now?
Janssen Pharmaceuticals ended a global trial after independent experts determined the vaccine was not effective. But there are other possibilities in the pipeline, scientists said.
‘Ebola Could Have Wiped Us All’: Slow Lockdown Haunts Uganda
The authorities hesitated to impose restrictions in the epicenter of the Ebola outbreak because of residual trauma from the Covid lockdown. Ebola then spread to the capital, killing dozens of Ugandans.
The End of Covid Vaccines at ‘Warp Speed’
Financial and bureaucratic barriers in the United States mean that the next generation of Covid vaccines may well be designed here, but used elsewhere.
Can New Vaccines Finally Eradicate Malaria?
Two new vaccines may finally turn back an ancient plague. But in unexpected ways, their arrival also complicates the path to ending the disease.